Alembic Pharma gains 5% on successful USFDA inspection of Panelav facility

The stock was up 5% at Rs 527 on the BSE in early morning trade after the company informed that the successful USFDA inspection at its API facility at Panelav with zero 483s. Shares of Alembic Pharmaceuticals were up 5% at Rs 527 per share on the BSE in early morning trade after the company informed about the successful United States Food and Drug Administration (US FDA) inspection at its API facility at Panelav with zero 483s.

To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php